ReviewFrontiers in endocrinology2022

PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases.

Yijun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.